Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Vehicle-Controlled Study to Assess the Efficacy of GX-03 When Used in a Population of Adult Individuals With Moderate to Severe Eczema

NCT07355075 is registered in ClinicalTrials.gov with Turn Therapeutics as lead sponsor.

NCT NCT07355075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07355075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Vehicle-Controlled Study to Assess the Efficacy of GX-03 When Used in a Population of Adult Individuals With Moderate to Severe Eczema
Lead sponsor
Turn Therapeutics
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 11, 2025
Completion date
January 20, 2027
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, eczema, eczema atopic dermatitis